Stealth donor gives millions to GOP candidates, causes Today is a deadline for campaigns in Minnesota to release detailed reports about who gives them money. One of the names that is sure to surface in those reports is Robert Cummins, a wealthy donor who stays out of the spotlight but wields tremendous power over Republican candidates and campaigns. Cummins and his family have given millions to conservative Minnesota candidates and causes over the past 15 years.6:20 a.m.
Koerner and Glover play the 400 Bar again Tonight, and every Wednesday night through February, local music icons "Spider" John Koerner and Tony Glover will take to the stage at the 400 Bar in Minneapolis.7:45 a.m.
Super Pac money to target Cravaack Every Wednesday we chat with one of our reporters in greater Minnesota to learn about some of the news they're tracking. MPR's Phil Picardi spoke with Minnesota Public Radio News reporter Dan Kraker who was in our Duluth bureau. They talked about a Super Pac that's going after Eight District Congressman Rep. Chip Cravaack.8:25 a.m.
Florida Win Boosts Romney To Front-Runner Status
After a stinging loss to Newt Gingrich in the South Carolina primary earlier this month, Mitt Romney is once again the front-runner in the Republican presidential race. Romney won the Florida primary Tuesday night by beating former House Speaker Newt Gingrich by 14 points.
S.C. Momentum Doesn't Help Gingrich In Florida
Newt Gingrich had hoped that his win in the South Carolina primary earlier this month would give him momentum going into Tuesday's nominating contest in Florida. But it didn't. He lost to Mitt Romney by 14 points.
In Booming Istanbul, A Clash Between Old And New
Istanbul is rapidly changing as Turkey's economy surges. Working-class neighborhoods are being cleared to make room for expensive villas, luxury hotels and upscale restaurants. A new documentary film warns that the latest mega-projects will damage the social and cultural fabric of the city.
Study: Segregation Declines Across U.S.
A study published by the Manhattan Institute for Policy Research indicates U.S. cities are more integrated now than they have been since 1910. The findings are based on information from the 2010 Census.
Occupy Movement Uses Colder Months To Unite
The Occupy Wall Street movement seized the world's attention after a group in New York claimed a small slice of land in the financial district. The movement rapidly spread to other cities, sparking a national discussion on income inequality and other issues. Things are quieter in New York, but the movement still has big plans.
Cystic Fibrosis Drug Wins Approval
The Food and Drug Administration approved the first drug that treats cystic fibrosis by addressing an underlying cause of the disease. But the medicine, called Kalydeco, will cost nearly $300,000 a year.
New Silica Rules Languish In Regulatory Black Hole
Last year it looked like stricter controls would be put in place to limit workers' exposure to dangerous silica dust. But for almost a year, the proposed regulations have been stalled at the White House Office of Management and Budget. Worker safety advocates are growing frustrated, but industry stakeholders say current regulations are sufficient.
Amazon Misses Earnings Expectations
Amazon.com announced its latest quarterly results, warning it could lose money in the current quarter. Revenue at the company was up 35 percent to more than $17 billion but analysts were expecting at least a billion more than that.
Obama Visits Washington D.C. Auto Show
President Obama is hoping to get some political mileage this November in states like Michigan and Ohio from his controversial rescue of the auto industry. While many Republicans, including Mitt Romney, were skeptical at the time, the president notes that U.S. carmakers are now profitable and hiring again.
Monsanto Accused In Suit Tied To Agent Orange
A class-action lawsuit claims Monsanto spread dioxin and other toxic substances when it made a primary ingredient for Agent Orange in West Virginia. Dioxin has been linked to cancer and other illnesses. At issue is whether Monsanto must pay millions to monitor the health of everyone in the case.